Table 4. Subgroup analysis of testosterone levels according to CKD status.
| Characteristic | Non-adjusted | Adjust I | Adjust II | |
|---|---|---|---|---|
| Age (y) | ||||
| 6–22 | 121.618 (17.447, 225.789) | 131.519 (44.954, 218.084) | - | |
| 23–49 | 44.957 (-10.484, 100.398) | 114.007 (80.196, 147.817) | 115.160 (21.702, 208.617) | |
| 50–85 | 23.649 (10.055, 37.243) | 33.496 (25.116, 41.877) | 45.002 (19.434, 70.571) | |
| Sex | ||||
| Male | 46.79 (31.10, 62.47) | 65.63 (50.44, 80.82) | 89.38 (41.80, 136.96) | |
| Female | 2.76 (0.94, 4.57) | 0.77 (-1.04, 2.58) 0.4054 | 0.27 (-4.78, 5.32) 0.9168 | |
| BMI (kg/cm2) | ||||
| ≤18.5 | -21.37 (-95.93, 53.19) | 60.22 (-9.97, 130.42) | 63.99 (-195.29, 67.30) | |
| >18.5, <24.9 | 52.51 (21.92, 83.11) | 46.75 (26.44, 67.07) | 73.90 (18.68, 129.12) | |
| ≥24.9 | 19.74 (6.49, 32.99) | 30.01 (21.55, 38.46) | 37.50 (9.71, 65.29) | |
| HBP status | ||||
| Yes | 37.410 (22.457, 52.363) | 29.889 (19.937, 39.841) | 39.152 (13.439, 64.866) | |
| No | -5.547 (-28.250, 17.156) | 63.010 (47.621, 78.399) | 73.265 (9.507, 137.024) | |
| DM status | ||||
| Yes | 12.87 (-5.52, 31.26) | 22.39 (11.08, 33.70) | 41.40 (6.68, 76.12) | |
| No | 23.17 (6.21, 40.13) | 27.16 (16.18, 38.14) | 36.30 (4.35, 68.25) | |
| Anemia | ||||
| Yes | -43.091 (-46.874, -39.308) | 23.803 (20.350, 27.255) | 6.718 (3.061, 10.375) | |
| No | 4.821 (-1.458, 11.101) | 57.604 (53.152, 62.057) | 33.503 (28.887, 38.118) | |
Values are presented as β (95% confidence interval).
Non-adjusted model adjust for: None; Adjust I model to adjust for: sex, age, BMI; Adjust II model adjust for: sex, age, BMI, total cholesterol, HDL, LDL, DM, waist, hemoglobin, race/ethnicity, education status, marital status, smoking status, HBP status, anemia, alcohol status.
CKD: chronic kidney disease, BMI: body mass index, HDL: high-density lipoprotein cholesterol, LDL: low-density lipoprotein cholesterol, DM: diabetes mellitus, HBP: high blood pressure.